Skip to NavigationSkip to content

Roche appoints new research and early development head

Published on: 15/03/18

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due to personal reasons, it has emerged. Furthermore, it has been announced that current Global Head of the Oncology Discovery and Translational Area for pRED, Dr William Pao, will succeed him in the role, effective 2 April.

A Yale and Harvard graduate and faculty member of the Memorial Sloan-Kettering Cancer Center, Dr Pao has served at Roche since 2014, arriving one year after Dr Reed. Prior to making the move to his current company, he held the dual roles of Professor of Medicine and Director of the Division of Hematology/Oncology at Vanderbilt University, and Director of Personalized Cancer Medicine at Vanderbilt-Ingram Cancer Center.

Roche praised Dr Pao in the announcement of his promotion, noting that he is recognised “for his groundbreaking work in translational medicine, mechanistic and clinical studies of targeted cancer therapeutics, and for his leadership in cancer genomics and personalised medicine”. He is the author of a number of scientific and medical publications, and has served as an advisor to associations including the National Cancer Institute, the American Association for Cancer Research and the American Society of Clinical Oncology. He is also the co-founder of MyCancerGenome, a unified genomics and clinical trial online portal. 

“I am delighted with the appointment of one of our most distinguished scientific leaders, William Pao, currently Global Head of the Oncology Discovery and Translational Area for pRED,” commented Roche CEO Severin Schwan. “Since joining Roche in 2014, William has been instrumental in the build-up of cancer immunotherapy and molecular targeted therapies.”

Schwan added: “I am thankful to have had John Reed with Roche over the past five years, and for all his many valuable contributions. I wish John all the best for his future.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches